LQDA · Insider Trading

Liquidia Corporation Common Stock

Every open-market purchase and sale reported by LQDA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
0
code P
Sales
22
code S
Reporting Insiders
17
current holders
LQDA — Recent Form 4 Transactions (latest 2026-10-13)
FiledInsiderRole TypeSharesValue
2026-10-13 Roger Jeffs Chief Executive Officer MIXED −4,578 −$932.55K
2026-10-13 Dana Boyle Chief Accounting Officer MIXED −2,714 −$167.80K
2026-10-13 Rajeev Saggar Chief Medical Officer MIXED −1,202 −$262.53K
2026-10-13 Sarah Krepp Chief Human Resource Officer MIXED −2,067 −$149.38K
2026-10-13 Jason Adair Chief Business Officer MIXED +2,947 −$207.93K
2026-10-13 Michael Kaseta CFO and COO MIXED −6,061 −$539.35K
2026-10-13 Sanjeev Khindri Chief Development Officer Sell −1,101 −$31.36K
2026-10-13 Russell Schundler General Counsel MIXED −3,525 −$389.95K
2026-10-13 Scott Moomaw Chief Commercial Officer MIXED −1,397 −$252.42K
2026-10-07 Stephen M Bloch Director Sell −235,477 −$6.39M
2026-09-15 Raman Singh Director MIXED — −$1.02M
2026-09-03 Sarah Krepp Chief Human Resource Officer Sell −274 −$18.57K
2026-08-25 Jason Adair Chief Business Officer MIXED −41,832 −$4.74M
2026-08-21 Katherine Rielly-Gauvin Director MIXED — −$3.95M
2026-08-19 Rajeev Saggar Chief Medical Officer MIXED −29,534 −$5.79M
2026-07-29 Dana Boyle Chief Accounting Officer Sell −1,600 −$140.05K
2026-07-29 Jason Adair Chief Business Officer Sell −688 −$60.22K
2026-07-24 Stephen M Bloch Director Sell −200,000 −$17.79M
2026-07-22 Stephen M Bloch Director Sell −78,596 −$6.29M
2026-07-14 Scott Moomaw Chief Commercial Officer MIXED −2,073 −$682.14K
2026-07-14 Sanjeev Khindri Chief Development Officer Sell −1,185 −$84.74K
2026-07-14 Roger Jeffs Chief Executive Officer MIXED −7,082 −$2.52M
2026-07-14 Michael Kaseta CFO and COO MIXED −7,551 −$1.46M
2026-07-14 Russell Schundler General Counsel MIXED −4,570 −$1.05M
2026-07-14 Rajeev Saggar Chief Medical Officer MIXED −1,908 −$709.82K
2026-07-14 Jason Adair Chief Business Officer MIXED +2,388 −$562.29K
2026-07-14 Dana Boyle Chief Accounting Officer MIXED −5,823 −$643.74K
2026-07-14 Sarah Krepp Chief Human Resource Officer MIXED −4,685 −$562.36K
2026-07-08 Stephen M Bloch Director Sell −75,000 −$6.05M
2026-07-06 Stephen M Bloch Director Sell −25,000 −$1.99M
2026-06-24 Stephen M Bloch Director Sell −100,000 −$7.57M
2026-06-18 Damian deGoa Director A +5,882 —
2026-06-18 Arthur S Kirsch Director A +5,882 —
2026-06-18 David Edward Johnson Director A +11,764 —
2026-06-18 Joanna Horobin Director A +5,882 —
2026-06-18 Stephen M Bloch Director A +5,882 —
2026-06-18 Raman Singh Director A +5,882 —
2026-06-18 Katherine Rielly-Gauvin Director A +5,882 —
2026-06-18 Paul B Manning Director A +5,882 —
2026-06-16 Stephen M Bloch Director Sell −196,111 −$14.01M
2026-06-15 Sarah Krepp Chief Human Resource Officer Sell −24,880 −$1.75M
2026-06-12 Stephen M Bloch Director Sell −388,223 −$26.63M
2026-06-10 Sanjeev Khindri Chief Development Officer Sell −4,134 −$270.61K
2026-06-10 Stephen M Bloch Director Sell −220,835 −$14.27M
2026-06-08 Paul B Manning Director Sell −200,000 −$12.78M
2026-06-08 Stephen M Bloch Director Sell −84,800 −$5.51M
2026-06-03 Arthur S Kirsch Director Sell −30,000 −$1.73M
2026-06-03 Sarah Krepp Chief Human Resource Officer Sell −276 −$16.80K
2026-05-28 Roger Jeffs Chief Executive Officer Sell −6,428 −$399.71K
2026-05-26 Roger Jeffs Chief Executive Officer Sell −75,000 −$4.58M
LQDA — Current Insider Holders
InsiderRole Shares HeldValue
David Edward Johnson Director 8,163,229 $280.41M
Roger Jeffs Chief Executive Officer 1,190,854 $40.91M
Paul B Manning Director 911,139 $31.30M
Russell Schundler General Counsel 617,341 $21.21M
Michael Kaseta CFO and COO 340,148 $11.68M
Scott Moomaw Chief Commercial Officer 181,487 $6.23M
Jason Adair Chief Business Officer 178,916 $6.15M
Dana Boyle Chief Accounting Officer 165,609 $5.69M
Rajeev Saggar Chief Medical Officer 150,685 $5.18M
Sarah Krepp Chief Human Resource Officer 120,486 $4.14M
Stephen M Bloch Director 104,570 $3.59M
Damian deGoa Director 92,353 $3.17M
Sanjeev Khindri Chief Development Officer 64,846 $2.23M
Arthur S Kirsch Director 46,637 $1.60M
Katherine Rielly-Gauvin Director 44,637 $1.53M
Raman Singh Director 44,637 $1.53M
Joanna Horobin Director 39,637 $1.36M
LQDA Insider Trading FAQ
Who are the insiders at LQDA?
17 officers, directors and 10%+ beneficial owners currently report holdings in LQDA via SEC Form 4.
Are LQDA insiders buying or selling?
Across the 50 most recent Form 4 filings for LQDA, 0 were open-market purchases (code P) and 22 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is LQDA insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent LQDA filing is dated 2026-10-13.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the LQDA quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.